Broadwood Partners, L.P., Director, 10% Owner at Lineage Cell Therapeutics, Inc. (LCTX), bought 13,461,540 shares at $1.04 ($14.0M) on 2024-02-06, disclosed to the SEC on 2024-02-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.04 | 6,730,770 | $7.0M | 50.0% |
| 2 | $1.04 | 6,730,770 | $7.0M | 50.0% |
| Total | $1.04 avg | 13,461,540 | $14.0M | 100% |
| Filing → |
| STAA | BUY | 2026-03-13 | $12.3M | — | Filing → |
| STAA | BUY | 2026-01-08 | $8.8M | — | Filing → |
| STAA | BUY | 2025-04-07 | $27.2M | — | Filing → |